Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04895475 · ClinicalTrials.gov registry record
Antibody Detection of Vaccine-Induced Secretory Effects
A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 61
- Enrollment target
NCT04895475 is a clinical trial that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 61 participants.
The verdict
NCT04895475 has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
The purpose of this research study is to conduct a prospective longitudinal surveillance research study, enrolling approximately 60 lactating mothers who receive the SARS-CoV-2 vaccine, and then following their clinical and laboratory parameters for up to 12 months. The overall goal is to investigate the characteristics of antibody formation in lactating women receiving SARS-CoV-2 vaccination, documenting the antibody isotypes, titers, duration, and transfer into milk over time.
Interventions
- BEHAVIORAL SARS-CoV-2 vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2021-02-19 |
| Est. Completion | 2023-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04895475
The ClinicalTrials.gov registry entry for NCT04895475 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SARS-CoV-2 vaccine is the first listed.
NCT04895475 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04895475 about?
NCT04895475 is a clinical study titled "Antibody Detection of Vaccine-Induced Secretory Effects". The purpose of this research study is to conduct a prospective longitudinal surveillance research study, enrolling approximately 60 lactating mothers who receive the SARS-CoV-2 vaccine, and then following their clinical and laboratory parameters for up to 12 months. The overall goal is to investigat...
What is the current status of trial NCT04895475?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2021-02-19. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT04895475?
The interventions under investigation include: SARS-CoV-2 vaccine (BEHAVIORAL).
Who is sponsoring clinical trial NCT04895475?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.